Exosomal ncRNAs in liquid biopsies for lung cancer

MS Hussain, G Gupta, N Ghaboura, E Moglad… - Clinica chimica acta, 2024 - Elsevier
Exosomal non-coding RNAs (ncRNAs) have become essential contributors to advancing
and treating lung cancers (LCs). The development of liquid biopsies that utilize exosomal …

Noncoding RNAs in the COVID-19 saga: an untold story

M Maqbool, MS Hussain, NK Shaikh, A Sultana… - Viral …, 2024 - liebertpub.com
In late 2019, the SARS-CoV-2 virus emerged as the cause of COVID-19, triggering a
worldwide pandemic of unprecedented scale. A detailed comprehension is being …

Connecting the dots: LncRNAs in the KRAS pathway and cancer

M Maqbool, MS Hussain, AS Bisht, A Kumari… - … -Research and Practice, 2024 - Elsevier
Long non-coding RNAs (lncRNAs) have been identified as important participants in several
biological functions, particularly their complex interactions with the KRAS pathway, which …

[HTML][HTML] Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancer

M Hashemi, EM Khosroshahi, S Asadi, M Tanha… - Non-coding RNA …, 2024 - Elsevier
Cancer progression results from the dysregulation of molecular pathways, each with unique
features that can either promote or inhibit tumor growth. The complexity of carcinogenesis …

Pharmacological, computational, and mechanistic insights into triptolide's role in targeting drug-resistant cancers

MS Hussain, S Mujwar, MA Babu, K Goyal… - Naunyn-Schmiedeberg's …, 2025 - Springer
As a promising candidate for tackling drug-resistant cancers, triptolide, a diterpenoid derived
from the Chinese medicinal plant Tripterygium wilfordii, has been developed. This review …

Exploring ncRNAs in epilepsy: From oxidative stress regulation to therapy

K Pant, A Sharma, SV Menon, H Ali, WH Almalki… - Brain Research, 2024 - Elsevier
Epilepsy is a prevalent neurological illness which is linked with high worldwide burdens.
Oxidative stress (OS) is recognized to be among the contributors that trigger the …

[HTML][HTML] A hepatocellular carcinoma model with and without parenchymal liver damage that integrates technical and pathophysiological advantages for therapy testing

K Benderski, P Schneider, P Kordeves, M Fichter… - Pharmacological …, 2025 - Elsevier
Hepatocellular Carcinoma (HCC) is the most common form of primary liver cancer, with
cirrhosis being its strongest risk factor. Interestingly, an increasing number of HCC cases is …

Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence

M Tufail, CH Jiang, N Li - Military Medical Research, 2025 - Springer
Cancer recurrence, driven by the phenomenon of tumor dormancy, presents a formidable
challenge in oncology. Dormant cancer cells have the ability to evade detection and …

Role of long non-coding RNAs in neurofibromatosis and Schwannomatosis: pathogenesis and therapeutic potential

MS Hussain, S Sharma, A Kumari, A Kamran… - …, 2024 - Taylor & Francis
Neurofibromatosis (NF) is identified as genetic disorder characterized by multiple tumors on
nerve tissues. NF1 is the most prevalent form, identified by neurofibromas and skin changes …

ML‐Based Screening of miRNA Inhibitors and Intervention of lncRNA/miRNA/mRNA Axis in Oncogenic KRAS‐Associated Colorectal Cancer

PS Ramalingam, DBTG Raj… - Advances in Public …, 2024 - Wiley Online Library
Mutant KRAS promotes proliferation and tumorigenesis in several cancers such as
colorectal cancer (CRC), pancreatic ductal adenocarcinoma (PDAC), and non–small cell …